Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-003720-11Phase 4Completed
Phase 4, randomised, open-label trial of remifentanil and propofol (2 arms), sponsored by GE HealthCare. Primary endpoints: Correlation of stress markers with predicted plasma opioid concentration and Intraoperative stress response at noxious stimuli. Started Aug 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-003720-11.